Atlas Trials

The Effect of Melatonin on Depression, Anxiety, Cognitive Function and Sleep Disturbances in Breast Cancer Patients

Clinical trial NCT01355523 · TERMINATED

Trial details

NCT number
NCT01355523
Sponsor
Melissa Voigt Hansen
Status
TERMINATED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Breast CancerDepression
Start date
2011-07-01
Primary completion
2013-01-01
Enrollment
54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.